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Abstract
Background: Infant colic (IC) affects up to 20% of infants in the first 4 months of life. Although IC is a benign affection that spontaneously 
resolves after the first 3-4 months of life, it is often a stressful problem for parents. 
Methods: Babies, aged ≤ 3 months, observed at family pediatrician office because a suspect of IC, were randomized in two groups of 3-week 
dietary intervention: Group 1, receiving non-analgesic, non-nutritive soothing maneuvers, continuing a standard formula; Group 2, receiving 
a partially hydrolyzed whey formula (w-pHF), containing GOS (0.5g/100ml), low content of lactose (2.5g/100ml) and low osmolarity (185 
mOsm). All infants performed clinical examinations at enrollment and after 7, 14 and 21 days. Number of colic episodes, and the number and 
consistency of fecal outputs were recorded daily. 
Results: Fifty infants with IC were enrolled and randomized: 25 in Group 1 and 25 in Group 2. The rate of infants with IC in Group 2 decreased 
significantly within 14 days compared to Group 1 and the number of bowel movements increased significantly within 7 days in Group 2 
compared to Group 1. Stool consistency significantly improved in Group 2 within 7 days. 
Conclusion: The studied formula could represent a useful approach in infants with IC reducing pharmacological treatments.
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Introduction
Infant colic (IC) affects up to 20% of infants in the first 4 months of 
life (1). Although IC is considered a benign affection that spontaneously 
resolves after the first 3-4 months of life, it is often a stressful 
problem for parents. It is associated with maternal depression, 
early breastfeeding cessation, shaken baby syndrome and milk 
formula changing(2-5).Despite decades of research, the cause of IC 
remains elusive. Psychosocial hypotheses include poor maternal-
infant interactions, maternal anxiety and depression, and difficult 
infant temperament. Gastrointestinal theories include increate 
intra-abdominal gas, hyperperistalsis, and visceral pain(6).A number 
of therapies have been tried, including use of hydrolyzed formulas, 
sucrose, herbal teas, soy formula, lactose-reduced formula, and 
fiber-enriched formulas, increased carrying, music, vibration or 
massage, and spinal manipulation; however, none has been proven 
to be effective(7). Alterations in gut microbiota composition have been 
described in subjects with IC(8,10).The modulation of gut microbiota 
might help the prevention of IC particularly in formula-fed infants, 
who have well-known differences in gut microbiota composition 
compared to breast-fed ones(11). Several reports in literature have 
shown that oligosaccharides (OS) supplementation in infant formulas 
may promote a healthy gut microbiota(12).Although potential benefits 
have been recently underlined by many authors(13-15), the European 
Society for Paediatric Gastroenterology,Hepatology andNutrition 
(ESPGHAN) Committee of Nutrition has concluded that there are only 
limited published data about prebiotics in dietetic products for infants 
and that well-designed randomized controlled trials are requested to 
validate clinical outcome measures of prebiotic effects in infants (16). 
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In this study, we aimed to evaluate the efficacy of a partially hydrolyzed 
whey formula containing OS on IC in a prospective randomized clinical 
trial. 
Patients and Methods 
Study design
A randomized controlled trial (RCT) was conducted in the city area 
of Naples, Italy, from 1st March to 31th September 2012. The RCT was 
conducted in collaboration with family pediatricians (FPs), operating, 
who care for children up to 14 years of age in the Italian Public Health 
System. Before the start of the study, all FPs involved attended an 
investigator meeting during which the study protocol was illustrated 
and discussed, and all procedures and definitions were shared.
Ethics
The Ethics Committee of the University “Federico II” of Naples 
approved the study. The trial was conducted in accordance with the 
Helsinki Declaration (Tokyo revision, 2004), according to the Good 
Clinical Practice Standards (CPMP/ICH/135/95), and the current Decree-
Law 196/2003 regarding personal data and all the requirements set out 
in the European regulations on this subject.
Study subjects
Otherwise healthy formula-fed infants (aged ≤ 3 months at the 
beginning of the study) observed by the FPs involved in the trial for the 
suspicion of IC were considered eligible for the study. Infant colic was 
defined by the presence of crying or fussing ≥ 3 hours/day for ≥3 days 
over seven days (7).The FPs consulted the clinical records of each infant 
for previous diseases and pharmacological treatments. At baseline, 
the health status of all study subjects was carefully assessed, and the 
possible presence of infectious diseases or of other morbidities was 
ruled out by the FPs through a full physical examination including: vital 
signs (body temperature, pulse rate, respiration rate, blood pressure); 
neurological status; growth parameters; nutritional status; hydration; 
skin evaluation; otoscopy; evaluation of oral cavity; respiratory/
abdomen/lymphonodes examination; genital examination. 
Exclusion criteria were: age >3 months, exclusive or partial breast-
feeding, suspected or documented systemic or congenital infections 
and evidence of significant genetic, cardiac, respiratory, hematological, 
gastrointestinal, metabolic or other systemic diseases, malformations 
of gastrointestinal or urinary or respiratory tract, gastrointestinal or 
urinary or respiratory tract surgery, failure to thrive (weight gain <100 
grams/week averaged from birth to the last recorded weight), cystic 
fibrosis, food allergy, and use of pre/pro/synbiotics or antibiotics in the 
2 weeks before the enrolment. 
Anamnestic, demographic and clinical data were collected by the FPs 
and reported in a specific clinical chart. 
Intervention 
Written informed consent was obtained from the parents/tutors of 
each subject. Then, according to a randomization list, infants were 
randomly allocated to one of the two groups of 3-week dietary 
intervention: Group 1, received non-analgesic, non-nutritive soothing 
maneuvers and continued the use of a standard formula; Group 2, 
received the same recommendations plus a partially hydrolyzed whey 
formula (w-pHF) (Humana Comfort, Humana Milan, Italy) containing 
GOS (0.5g/100ml), low content of lactose (2.5g/100ml) and low 
osmolarity (185 mOsm). 
Study products were commercially available as formula powder in 
Italy; the price was the same, and the packaging was very similar. The 
composition of the study formulas is reported in Table 1. 
The FPs allocated the next available number on entry into the trial, 
and instructed parents about the daily amount of the assigned study 
product, the method of preparation, and how to compile a structured 
diary to record symptoms. Parents recorded daily the number of IC 
episodes, and the number and consistency of fecal outputs during the 
21 days of study.
All infants performed a full clinical examination at enrollment and after 
1, 2 and 3 weeks. Adverse reactions were checked at each visit. 
Table 1: Composition per 100 ml of the studied formulas.
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Study outcomes
Main study outcome was the rate of subject presenting IC after 3 
weeks of dietary treatment. Secondary outcomes were the daily 
number of bowel movements and the stool consistency score (graded 
as in Bristol scale).
Sample size calculation
To detect a change of at least 30% in the rate of subjects with 
diagnosis of IC after 3 weeks of dietary treatment, with a power of 
0.85 at an alpha level of 0.05 (Pearson's Chi-square, two-tailed test), 
and considering a possible drop out, we calculated that 25 children 
per group were needed. Randomization was based on a list with 
consecutive numbers with an allocation ratio of 1:1 between Group 1 
and Group 2. The software used to generate the randomization list 
was randomizer.org. 
Statistical analysis
The Kolmogorov-Smirnov test was used to determine whether 
variables were normally distributed.  Data were reported as mean and 
standard deviation. The χ2 test and Fisher’s exact test were used for 
categorical variables. We used the t-test to evaluate differences among 
continuous variables. The level of significance for all statistical tests 
was 2-sided, p < 0.05. All analyses were conducted by a statistician 
blinded to patient group assignment, using SPSS, version 16.0 for 
Windows (SPSS Inc., Chicago, IL, USA).
Results
Fifty-six consecutive infants with IC were assessed for eligibility. Six 
subjects were excluded because they did not meet inclusion criteria, 
50 infants were enrolled and randomized in the two study groups: 
25 in Group 1 and 25 in Group 2 (Figure 1). At enrollment, the infants 
in the two study groups showed similar demographic and clinical 
characteristics (Table 2). All subjects were formula fed-infants, born at 
term with a birth weight adequate for gestational age, regular weight 
gain, weight for length ratios between 10th and 90th percentiles 
according to the World Health Organization growth charts, and 
negative physical examination. 
In Figure 2 is reported the rate of subjects with IC during the study 
period. At 2 and 3 weeks the rate of subjects with IC resulted 
significantly lower in subjects enrolled in Group 2 compared to Group 1. 
In Figure 3 is depicted the mean of number of bowel movements 
(mean/week) during the study period. The number of bowel 
movements increased significantly starting from the first week 
of treatment in infants enrolled in Group 2. Concomitantly stool 
consistency pattern changed significantly starting from the first week 
of dietary intervention only in infants enrolled in Group 2 (Figure 4).
No adverse events related to the consumption of the formulas 
occurred during the study. No differences were detected in the daily 
intake of the formulas between the two study groups. No significant 
changes were observed for body weight and height gain in infants 
enrolled in the two groups during the study period (data not shown).
Group  1 
Healthy Control
Group 2 
Treated with w-pHF
N. 25 25
Male, n (%) 12(48) 12(48)
Age, m (±SD) 1.84 (0.7) 1.80 (0.9)
Body weight at study entry, kg (±SD) 5266.4 (1009) 5250.8 (1084.7)
Lenth at study entry, cm (±SD) 57.8 (3.1) 56.7 (4.3)
Head circumference at study entry, cm (±SD) 39.7 (2.0) 38.8 (2.7)
Body weight After 3 wks, kg (±SD) 6296.4(972.4) 6198.0 (1257.4)
Length after 3 wks, cm (±SD) 61.5 (2.8) 59.9 (4.5)
Head circumference after 3 wks, cm (±SD) 42.0 (1.9) 40.7 (3.2)
Table 2: Baseline main demographic and clinical characteristics of the study population
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Figure 1: Flow diagram of the trial of dietary intervention for the treatment of infant colic.
Figure 2: Colic episodes over the course of the study in the two groups
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Figure 3: Bowel movements over the course of the study in the two groups.
Time Group 1 vs Group 2p
Bowel movements
(mean/week)
Baseline ns
1st Week <0.0001
2nd Week ns
3rd Week <0.0001
Time Group 1p
Group 2
p
Bowel movements
(mean/week)
Baseline vs 1st week 0.015 ns
Baseline vs 2nd week ns ns
Baseline vs 3rd week 0.002 0.038
1st vs 2nd week ns ns
1st vs 3rd week ns ns
2nd vs 3rd week ns ns
Group 1: healthy control
Group 2: treated with w-pHF
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Figure 4: Stool consistency over the course of the study in the two groups.
Time Group 1 vs Group 2p
Bristol score
(mean/week)
Baseline ns
1st Week <0.0001
2nd Week <0.0001
3rd Week <0.0001
Time Group 1p
Group 2
p
Bristol score
(mean/week)
Baseline vs 1st week <0.0001 <0.0001
Baseline vs 2nd week 0.046 <0.0001
Baseline vs 3rd week ns <0.0001
1st vs 2nd week <0.0001 <0.0001
1st vs 3rd week <0.0001 <0.0001
2nd vs 3rd week ns <0.0001
Group 1: healthy control
Group 2: treated with w-pHF
42
International Journal of Nutritional Science and Food Technology Volume 4 Issue 6, August 2018
Citation: Roberto Berni Canani et al. (2018), Efficacy of a partially hydrolyzed whey formula on infant colic: a randomized controlled trial. 
Int J Nutr Sci & Food Tech. 4:6, 37-44
Discussion 
In this RCT we investigated the efficacy of a w-pHF containing 
prebiotic on IC. Our findings show that w-pHF, containing GOS, low 
content of lactose and low osmolarity were effective against IC. 
The underlying mechanism accounting for the reduction of IC is not 
completely known, but it is likely that this could be influenced by 
different factors. Several investigators have examined the effect of 
different dietary interventions on IC. In bottle-fed infants, a variable 
degree of improvement in symptoms of IC has been observed by 
using hydrolyzed cow milk proteins formulae (17,18). In these infants, 
the reduction of colic episodes could be influenced not only by a 
downregulation of allergic response, but also by beneficial effects 
of other factors on bowel digestive functions (19). In fact, partially 
hydrolysed bovine proteins can accelerate gastrointestinal transit-
time via reduction of opioid activity released during digestion, as 
reported in an experimental study by Mihatsch et al. (20). 
Our study showed that the gastrointestinal comfort of infants fed the 
experimental formula was superior to that of infants fed the standard 
control formula. Infants in the experimental group had significantly 
less hard and more soft stools than the control group. Moreover, the 
experimental group tended to have a higher stool frequency than 
the control group. These results support the view of improved gut 
comfort in terms of stool consistency and gastrointestinal transit.
Growing evidence shows a role for OS in host microbial interactions 
for human health (21). Several studies have been published, specifically 
investigating the effect of prebiotics on microbiota growth in the 
infant’s gastrointestinal tract. Infant colics are usually associated 
with lower Lactobacillus and Bifidobacterium colonies and increased 
anaerobic Clostridium species in place of anaerobic bacteroides species 
and Bifidobacterium species (22). Giovannini et al. demonstrated that 
a formula supplemented with GOS had an efficient performance on 
gut microbiota, mimicking human milk promotion of Bifidobacterium 
growth and reduction of Clostridium after an initial period of one 
month. In line with our results, they showed that the tested formula 
containing GOS had a significant effect in lowering risk rates of colic 
and regurgitation when comparing with the standard formula, with a 
boosting effect on the beneficial bacterial flora and an inhibiting effect 
on Clostridium growth (23).
The low content of lactose in our tested formula also seems to improve 
gut homeostasis. Colic can result directly from the hyper-peristaltic 
stimulus of the fluid load imposed by the osmotic action of unabsorbed 
lactose in the small intestine, and gas or pharmacologically active 
metabolites might be responsible for the symptomatic signs. In many 
susceptible infants, this excess of gas is responsible for triggering 
colic. This model of colic implies that symptoms could be relieved by 
reducing the lactose content of the infant feed. In a non-randomized, 
non-placebo-controlled pilot study, Infante et al. demonstrates that 
the use of an adapted infant formula with a low lactose concentration 
leads to clinical improvement and a decrease in expired hydrogen in 
colicky infants (24). According to these results, our study infants with 
colic might benefit from this specific adapted formula because of its 
low content of lactose compared to a standard formula.
In conclusion, our study provides compelling evidences for the 
relation between IC reduction and type of formula used, supporting 
the hypothesis that infants fed with a w-pHF, containing OS, with low 
content of lactose and low osmolarity, have a significant improvement 
of IC. It is probable that all the above-mentioned factors (quality of 
proteins, low content of lactose, prebiotic and modulation of gut 
microbiota) may contribute to the positive effects of the tested 
formula, but further studies are needed to clarify which one could 
have a prevalent action. The studied formula could represent a useful 
baseline approach for colic treatment in otherwise healthy infants, 
reducing pharmacological treatments.  
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